Saba Annigeri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Saba Annigeri has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Arindam Ghosh
Department of Neonatology, Medical College and Hospital, Kolkata, India
5 shared publications - Jayant Prakash
Department of Paediatrics, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
2 shared publications - Rakesh Kumar
Department of Paediatrics, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
2 shared publications Anupama Nair
Midnapore Medical College and Hospital
1 shared publicationArindam Ghosh
Department of Paediatrics, Medical College and Hospital, West Bengal, India
1 shared publication- Arpan Dutta
Dept of Paediatrics R.G. Kar Medical College and Hospital Kolkata West Bengal India
1 shared publication
Latest Publications
- Open Access
- 14 March 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Medical and Paediatric Oncology
- Vol. 47 (03) , 218-225
Incidence and Spectrum of Childhood Tumors: A Three-Year Hospital-Based Registry Review from a Tertiary Center in Patna
Childhood cancers, though relatively uncommon, remain a leading cause of mortality and morbidity among children in low- and middle-income countries. Reliable epidemiological data from Eastern India, particularly from Bihar, remain limited. Despite the recent initiation of a population-based cancer registry (PBCR) in Bihar in 2018, its nonstatewide coverage hinders a comprehensive assessment of the disease burden and resource allocation for the entire region. To describe the incidence, spectrum, and demographic distribution of childhood tumors at a tertiary care center in Patna, Bihar, India, and to estimate the crude incidence rate (CIR) and age-standardized incidence rate (ASIR). A hospital-based cancer registry analysis was conducted at a tertiary care referral center in Patna, between January 2023 and September 2025. All newly diagnosed tumors in individuals aged 0 to 19 years (pediatric age group), confirmed histologically, cytologically, or by multidisciplinary consensus, were included. Malignancies were classified according to the International Classification of Childhood Cancer, third edition. Incidence rates were computed using the projected pediatric population of Patna, derived from the 2011 Census, and expressed as CIR and ASIR (per million person-years) with 95% confidence intervals (CI). Among 798 included patients, 756 (94.7%) had malignant and 42 (5.3%) benign tumors. The mean age at diagnosis was 7.5 ± 4.4 years, with a marked male predominance (M:F = 1.77:1). Solid malignancies (59.7%) outnumbered hematological malignancies (40.3%). The most common cancers were acute lymphoblastic leukemia (14.7%), Hodgkin lymphoma (13.4%), and retinoblastoma (11.4%). Among Patna-resident cases (n = 537), the CIR was 100.5 per million (95% CI: 93.2–107.8) and the ASIR was 106.5 per million. The highest age-specific incidence occurred in the <5-year group (29.8 per million). Embryonal tumors predominated in younger children, whereas lymphomas and bone sarcomas were more frequent among those aged 10 to <15 years. This hospital registry study at Patna reveals a substantial pediatric cancer burden, with a predominance of solid malignancies and a significant male excess. The observed high frequency of retinoblastoma and Hodgkin lymphoma, along with elevated CIR and ASIR values, underscores the urgent need for expanded PBCR coverage to accurately capture the disease burden and inform pediatric oncology planning in the region.
- 14 March 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Medical and Paediatric Oncology
- Vol. 47 (03) , 218-225
Open AccessIncidence and Spectrum of Childhood Tumors: A Three-Year Hospital-Based Registry Review from a Tertiary Center in Patna
Childhood cancers, though relatively uncommon, remain a leading cause of mortality and morbidity among children in low- and middle-income countries. Reliable epidemiological data from Eastern India, particularly from Bihar, remain limited. Despite the recent initiation of a population-based cancer registry (PBCR) in Bihar in 2018, its nonstatewide coverage hinders a comprehensive assessment of the disease burden and resource allocation for the entire region. To describe the incidence, spectrum, and demographic distribution of childhood tumors at a tertiary care center in Patna, Bihar, India, and to estimate the crude incidence rate (CIR) and age-standardized incidence rate (ASIR). A hospital-based cancer registry analysis was conducted at a tertiary care referral center in Patna, between January 2023 and September 2025. All newly diagnosed tumors in individuals aged 0 to 19 years (pediatric age group), confirmed histologically, cytologically, or by multidisciplinary consensus, were included. Malignancies were classified according to the International Classification of Childhood Cancer, third edition. Incidence rates were computed using the projected pediatric population of Patna, derived from the 2011 Census, and expressed as CIR and ASIR (per million person-years) with 95% confidence intervals (CI). Among 798 included patients, 756 (94.7%) had malignant and 42 (5.3%) benign tumors. The mean age at diagnosis was 7.5 ± 4.4 years, with a marked male predominance (M:F = 1.77:1). Solid malignancies (59.7%) outnumbered hematological malignancies (40.3%). The most common cancers were acute lymphoblastic leukemia (14.7%), Hodgkin lymphoma (13.4%), and retinoblastoma (11.4%). Among Patna-resident cases (n = 537), the CIR was 100.5 per million (95% CI: 93.2–107.8) and the ASIR was 106.5 per million. The highest age-specific incidence occurred in the <5-year group (29.8 per million). Embryonal tumors predominated in younger children, whereas lymphomas and bone sarcomas were more frequent among those aged 10 to <15 years. This hospital registry study at Patna reveals a substantial pediatric cancer burden, with a predominance of solid malignancies and a significant male excess. The observed high frequency of retinoblastoma and Hodgkin lymphoma, along with elevated CIR and ASIR values, underscores the urgent need for expanded PBCR coverage to accurately capture the disease burden and inform pediatric oncology planning in the region.
- Open Access
- 20 January 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (1) , 27-34
Utility of Phoenix Sepsis Score for Predicting Mortality in Pediatric Sepsis: A Prospective Analytical Study from a Resource-limited Pediatric Intensive Care Unit in Eastern India
Sepsis remains a leading cause of pediatric in-hospital mortality, particularly in resource-limited settings. The Pediatric Sequential Organ Failure Assessment (p-SOFA) score is widely used to guide prognostication, but its performance in children is suboptimal. The Phoenix Sepsis Score (PSS), developed specifically for pediatric patients, may offer improved predictive accuracy, yet validation data from Eastern India are lacking. We aimed to evaluate and compare the predictive performance of the PSS and p-SOFA scores for in-hospital mortality among children with sepsis admitted to a resource-limited pediatric intensive care unit (PICU) in Eastern India. This prospective analytical study enrolled children aged 1 month to 15 years with suspected or confirmed sepsis over 18 months. The PSS and p-SOFA scores were recorded on day 1 and day 3. Predictive performance for in-hospital mortality was assessed using the areas under the receiver-operating characteristic curve (AUROC), area under the precision–recall curve (AUPRC), sensitivity, specificity, positive predictive value, and negative predictive value. Multivariable logistic regression was used to estimate adjusted odds ratios (aOR) for mortality. Among 105 included children, 21 (20%) died during hospital stay. Non-survivors had significantly higher PSS and p-SOFA scores on both day 1 and day 3 (p < 0.001). On day 3, the PSS showed superior predictive performance (AUROC 0.910; AUPRC 0.678) compared to p-SOFA (AUROC 0.861; AUPRC 0.595). A PSS ≥5 on day 3 was associated with 96% sensitivity and significantly increased odds of in-hospital mortality (aOR 40.0, 95% CI: 35.1–47.5). Both scores are effective for mortality prediction, but the PSS demonstrated superior sensitivity, ease of use, and robustness in resource-limited environments. The PSS may serve as a more practical tool for early prognostication in pediatric sepsis. Kumar R, Ghosh A, Annigeri S, Prakash J, Jana D. Utility of Phoenix Sepsis Score for Predicting Mortality in Pediatric Sepsis: A Prospective Analytical Study from a Resource-limited Pediatric Intensive Care Unit in Eastern India. Indian J Crit Care Med 2026;30(1):27–34.
- 20 January 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (1) , 27-34
Open AccessUtility of Phoenix Sepsis Score for Predicting Mortality in Pediatric Sepsis: A Prospective Analytical Study from a Resource-limited Pediatric Intensive Care Unit in Eastern India
Sepsis remains a leading cause of pediatric in-hospital mortality, particularly in resource-limited settings. The Pediatric Sequential Organ Failure Assessment (p-SOFA) score is widely used to guide prognostication, but its performance in children is suboptimal. The Phoenix Sepsis Score (PSS), developed specifically for pediatric patients, may offer improved predictive accuracy, yet validation data from Eastern India are lacking. We aimed to evaluate and compare the predictive performance of the PSS and p-SOFA scores for in-hospital mortality among children with sepsis admitted to a resource-limited pediatric intensive care unit (PICU) in Eastern India. This prospective analytical study enrolled children aged 1 month to 15 years with suspected or confirmed sepsis over 18 months. The PSS and p-SOFA scores were recorded on day 1 and day 3. Predictive performance for in-hospital mortality was assessed using the areas under the receiver-operating characteristic curve (AUROC), area under the precision–recall curve (AUPRC), sensitivity, specificity, positive predictive value, and negative predictive value. Multivariable logistic regression was used to estimate adjusted odds ratios (aOR) for mortality. Among 105 included children, 21 (20%) died during hospital stay. Non-survivors had significantly higher PSS and p-SOFA scores on both day 1 and day 3 (p < 0.001). On day 3, the PSS showed superior predictive performance (AUROC 0.910; AUPRC 0.678) compared to p-SOFA (AUROC 0.861; AUPRC 0.595). A PSS ≥5 on day 3 was associated with 96% sensitivity and significantly increased odds of in-hospital mortality (aOR 40.0, 95% CI: 35.1–47.5). Both scores are effective for mortality prediction, but the PSS demonstrated superior sensitivity, ease of use, and robustness in resource-limited environments. The PSS may serve as a more practical tool for early prognostication in pediatric sepsis. Kumar R, Ghosh A, Annigeri S, Prakash J, Jana D. Utility of Phoenix Sepsis Score for Predicting Mortality in Pediatric Sepsis: A Prospective Analytical Study from a Resource-limited Pediatric Intensive Care Unit in Eastern India. Indian J Crit Care Med 2026;30(1):27–34.
- Open Access
- 1 January 2025
- Published by Japanese Society for Pediatric Endocrinology in Clinical Pediatric Endocrinology
- Vol. 34 (4) , 254-259
Double ‘A’ phenotypes with mineralocorticoid deficiency: A rare presentation of Allgrove syndrome
Allgrove syndrome (AS), an uncommon multisystem disorder, is characterized by the classic clinical triad of alacrimia, achalasia, and adrenal insufficiency, and is typically limited to glucocorticoid deficiency with preserved mineralocorticoid (MC) function. Here, we present the case of a 5-yr-old girl with alacrimia since birth, failure to thrive, and generalized hyperpigmentation for the past two years, who presented to the emergency department with an altered sensorium. Upon admission, the patient was found to have hypoglycemia and hyponatremia. After subsequent evaluation, the patient was diagnosed with phenotypically incomplete AS with mineralocorticoid insufficiency and harbored a novel homozygous mutation in exon 7 of the AAAS gene (c.618del; p.Ser207LeufsTer84). Treatment with hydrocortisone and fludrocortisone yielded remarkable outcomes. Given the variable presentations of this condition, a high index of clinical suspicion and awareness of atypical features are essential for early diagnosis and initiation of coordinated care to prevent unnecessary morbidity and mortality. When AS is suspected, molecular genetic testing should be performed to confirm the diagnosis, plan management, and provide genetic counseling.
- 1 January 2025
- Published by Japanese Society for Pediatric Endocrinology in Clinical Pediatric Endocrinology
- Vol. 34 (4) , 254-259
Open AccessDouble ‘A’ phenotypes with mineralocorticoid deficiency: A rare presentation of Allgrove syndrome
Allgrove syndrome (AS), an uncommon multisystem disorder, is characterized by the classic clinical triad of alacrimia, achalasia, and adrenal insufficiency, and is typically limited to glucocorticoid deficiency with preserved mineralocorticoid (MC) function. Here, we present the case of a 5-yr-old girl with alacrimia since birth, failure to thrive, and generalized hyperpigmentation for the past two years, who presented to the emergency department with an altered sensorium. Upon admission, the patient was found to have hypoglycemia and hyponatremia. After subsequent evaluation, the patient was diagnosed with phenotypically incomplete AS with mineralocorticoid insufficiency and harbored a novel homozygous mutation in exon 7 of the AAAS gene (c.618del; p.Ser207LeufsTer84). Treatment with hydrocortisone and fludrocortisone yielded remarkable outcomes. Given the variable presentations of this condition, a high index of clinical suspicion and awareness of atypical features are essential for early diagnosis and initiation of coordinated care to prevent unnecessary morbidity and mortality. When AS is suspected, molecular genetic testing should be performed to confirm the diagnosis, plan management, and provide genetic counseling.
- Open Access
- 5 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 53 (3) , 252-259
Correlation between serum vitamin D status and childhood asthma: An analytical study from Eastern India
Background: Epidemiological studies determining the influence of vitamin D status on childhood asthma remain inconclusive and data are scarce from eastern India.Objectives: To evaluate the serum vitamin D status in children with asthma and investigate its association with disease controlMethod: This cross-sectional analytical study included 90 asthmatics and 90 healthy children, aged 5-12 years over one year. Serum 25-hydroxyvitamin D was measured via a chemiluminescence method. Univariate and multivariate analyses were performed to investigate the risk factors for childhood asthma and its level of control. Pearson correlation analysis was applied to identify the correlation between serum vitamin D concentration and spirometry parameters.Results: The proportion of vitamin D deficiency and insufficiency among asthmatics and healthy children was 32.2% vs 14.4% and 41.1% vs 31.1%, respectively (p<0.001). Mean serum vitamin D level was significantly low in children with uncontrolled asthma (12.59±3.56 ng/mL) compared to those with partially (25.05±5.32 ng/mL) or well-controlled (25.54±5.49 ng/mL) diseases. In multivariate analysis, vitamin D deficiency (AOR: 4.37, 95% CI: 2.31–5.63) and family history of asthma (AOR:2.35, 95% CI:1.33–3.99) were found to be statistically significant predictors of childhood asthma. The FEV1 and PEFR were positively correlated with serum vitamin D levels.Conclusions: There was a high prevalence of vitamin D deficiency/ insufficiency in Eastern Indian children with asthma. Vitamin D deficiency was also associated with an increased risk of childhood asthma as well as its level of control.
- 5 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 53 (3) , 252-259
Open AccessCorrelation between serum vitamin D status and childhood asthma: An analytical study from Eastern India
Background: Epidemiological studies determining the influence of vitamin D status on childhood asthma remain inconclusive and data are scarce from eastern India.Objectives: To evaluate the serum vitamin D status in children with asthma and investigate its association with disease controlMethod: This cross-sectional analytical study included 90 asthmatics and 90 healthy children, aged 5-12 years over one year. Serum 25-hydroxyvitamin D was measured via a chemiluminescence method. Univariate and multivariate analyses were performed to investigate the risk factors for childhood asthma and its level of control. Pearson correlation analysis was applied to identify the correlation between serum vitamin D concentration and spirometry parameters.Results: The proportion of vitamin D deficiency and insufficiency among asthmatics and healthy children was 32.2% vs 14.4% and 41.1% vs 31.1%, respectively (p<0.001). Mean serum vitamin D level was significantly low in children with uncontrolled asthma (12.59±3.56 ng/mL) compared to those with partially (25.05±5.32 ng/mL) or well-controlled (25.54±5.49 ng/mL) diseases. In multivariate analysis, vitamin D deficiency (AOR: 4.37, 95% CI: 2.31–5.63) and family history of asthma (AOR:2.35, 95% CI:1.33–3.99) were found to be statistically significant predictors of childhood asthma. The FEV1 and PEFR were positively correlated with serum vitamin D levels.Conclusions: There was a high prevalence of vitamin D deficiency/ insufficiency in Eastern Indian children with asthma. Vitamin D deficiency was also associated with an increased risk of childhood asthma as well as its level of control.
- 3 December 2020
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 31 (4) , 651-653
Low-dose steroid-induced bradyarrhythmias and treatment refractory hypokalaemia: a case report
Corticosteroid therapy has become an important modality of treatment for diseases in which rapid control of immunoinflammatory processes is required. However, one of the serious, but less known adverse effect of this therapy is cardiac arrhythmias. This includes both tachyarrhythmias and bradyarrhythmias. Corticosteroid use may also be associated with electrolyte imbalances like hypokalaemia by its mineralocorticoid activity. Those side effects are mainly seen with high-dose intravenous methyl-prednisolone or oral pulse dose prednisolone therapy. Here we report our experience in a child with warm idiopathic autoimmune haemolytic anaemia who developed sinus bradyarrhythmias and treatment refractory hypokalaemia during low-dose steroid therapy with reduction in heart rate by 60% of baseline.
- 3 December 2020
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 31 (4) , 651-653
Low-dose steroid-induced bradyarrhythmias and treatment refractory hypokalaemia: a case report
Corticosteroid therapy has become an important modality of treatment for diseases in which rapid control of immunoinflammatory processes is required. However, one of the serious, but less known adverse effect of this therapy is cardiac arrhythmias. This includes both tachyarrhythmias and bradyarrhythmias. Corticosteroid use may also be associated with electrolyte imbalances like hypokalaemia by its mineralocorticoid activity. Those side effects are mainly seen with high-dose intravenous methyl-prednisolone or oral pulse dose prednisolone therapy. Here we report our experience in a child with warm idiopathic autoimmune haemolytic anaemia who developed sinus bradyarrhythmias and treatment refractory hypokalaemia during low-dose steroid therapy with reduction in heart rate by 60% of baseline.